Filing Details
- Accession Number:
- 0001567619-19-018774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-26 10:51:30
- Reporting Period:
- 2019-09-25
- Accepted Time:
- 2019-09-26 10:51:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70487 | National Research Corp | NRC | Services-Commercial Physical & Biological Research (8731) | 470634000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654405 | D. Steven Jackson | C/O National Research Corporation 1245 Q Street Lincoln NE 68508 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-09-25 | 4,000 | $60.79 | 93,596 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | $15.23 | 2026-01-05 | 21,535 | 21,535 | Direct | |
| Common Stock | Employee Stock Option (Right to Buy) | $18.80 | 2027-01-04 | 17,608 | 17,608 | Direct | |
| Common Stock | Employee Stock Option (Right to Buy) | $36.80 | 2028-01-03 | 12,228 | 12,228 | Direct | |
| Common Stock | Employee Stock Option (Right to Buy) | $38.30 | 2029-01-03 | 11,749 | 11,749 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-01-05 | 21,535 | 21,535 | Direct |
| 2027-01-04 | 17,608 | 17,608 | Direct |
| 2028-01-03 | 12,228 | 12,228 | Direct |
| 2029-01-03 | 11,749 | 11,749 | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually received ranged from $60.75 to $60.8945. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
- This option becomes fully exercisable on January 5, 2021.
- This option becomes fully exercisable on January 4, 2022.
- This option becomes fully exercisable on January 3, 2023.
- This option becomes fully exercisable on January 3, 2024.
Billionaire Hedge Funds
